GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: IWY-357 | NVP-IWY357
Compound class:
Synthetic organic
Comment: IWY357 is an orally bioavailable compound with antimalarial activity [2]. It is one of the antimalarials in the Medicine's for Malaria Venture (MMV) pipeline (link here) and is intended as a treatment for uncomplicated malaria with potential for resistance management. The chemical structure for IWY357 was revealed in the "First Time Disclosures" session at the ACS (Fall) 2024 meeting in Denver and it is one of the structures claimed in patent WO2023180964A1 [1]. The mechanism of action of IWY357 is not fully resolved.
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Ligand families/groups | Antimalarial ligands |
Synonyms ![]() |
| IWY-357 | NVP-IWY357 |
Database Links ![]() |
|
| CAS Registry No. | 3052672-51-9 (source: Scifinder) |
| GtoPdb PubChem SID | 500839934 |
| PubChem CID | 171922539 |
| Search Google for chemical match using the InChIKey | HPXREYVNZDJZJA-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | HPXREYVNZDJZJA |
| UniChem Compound Search for chemical match using the InChIKey | HPXREYVNZDJZJA-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | HPXREYVNZDJZJA-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖